Oragenics Inc (NYSEAMERICAN:OGEN) shares saw unusually-high trading volume on Thursday . Approximately 7,020,091 shares traded hands during trading, an increase of 331% from the previous session’s volume of 1,629,727 shares.The stock last traded at $1.05 and had previously closed at $0.88.

Oragenics (NYSEAMERICAN:OGEN) last released its quarterly earnings results on Tuesday, November 13th. The biotechnology company reported ($0.35) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.22) by ($0.13).

COPYRIGHT VIOLATION NOTICE: This story was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was copied illegally and reposted in violation of US and international copyright and trademark law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2019/01/12/oragenics-ogen-sees-large-volume-increase.html.


Oragenics, Inc focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients.

Recommended Story: What are earnings reports?

Receive News & Ratings for Oragenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oragenics and related companies with MarketBeat.com's FREE daily email newsletter.